STOCK TITAN

Insider sale: Aura Biosciences (NASDAQ: AURA) reports 12,079-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Aura Biosciences submitted a Form 144 notice reporting an insider sale of 12,079 shares of Common Stock on 02/17/2026. The filing also shows a 24,000 restricted stock unit award granted on 04/02/2024 and lists 64,150,468 shares outstanding as of 04/16/2026.

Positive

  • None.

Negative

  • None.
Form type Form 144 insider resale notice
Shares sold (reported) 12,079 shares sale on 02/17/2026 by Conor Kilroy
Sale proceeds (line item) $61,037.31 numeric value adjacent to the 12,079-sale line
Restricted Stock Units granted 24,000 units grant dated 04/02/2024 under 2021 Stock Option and Incentive Plan
Shares outstanding 64,150,468 shares listed with date 04/16/2026
Restricted Stock unit award financial
"Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan"
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
Form 144 regulatory
"CONTENT METADATA: form_type: "144""
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Morgan Stanley Smith Barney LLC other
"Common Stock | Morgan Stanley Smith Barney LLC Drive 200 West Civic Center"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did AURA disclose in the Form 144?

The filing reports an insider sale of 12,079 shares on 02/17/2026. It also records a 24,000 restricted stock unit award granted 04/02/2024 and shows 64,150,468 shares outstanding as of 04/16/2026.

Who executed the sale reported in AURA's Form 144?

The sale was reported in the filing under the name Conor Kilroy. The record lists the sale date as 02/17/2026 and a numeric amount of 12,079 shares associated with that line in the excerpt.

How many restricted stock units does AURA show in the excerpt?

The excerpt shows a Restricted Stock Unit award of 24,000 units. The award is dated 04/02/2024 and is described as subject to vesting requirements under the company plan.

What broker is listed for the transaction in the filing?

Brokerage listed: Morgan Stanley Smith Barney LLC. The filing includes an address line for that broker and associates the Common Stock transaction with Nasdaq trading.